{"cluster": 47, "subcluster": 3, "abstract_summ": "Invasive fungal infections (Aspergillus, Mucorales, and Pneumocystis jirovecii) account for about 15% of severe respiratory infections, whereas parasites rarely cause severe acute infections in immunocompromised patients.With the expanding use of molecular assays, viral pathogens are increasingly recognized among critically ill adult patients with community-acquired severe respiratory illness; studies have detected respiratory viral infections (RVIs) in 17\u201353% of such patients.In addition, novel pathogens including zoonotic coronaviruses like the agents causing Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) and the 2019 novel coronavirus (2019 nCoV) are still being identified.The frequency of respiratory infections as an infection in cancer patients is high.Established viral infections that may complicate patient management include human immunodeficiency virus, hepatitis B and C, and, more recently, the novel coronavirus SARS-CoV-2.", "title_summ": "Diagnosis of severe respiratory infections in immunocompromised patientsCommunity-Acquired PneumoniaViral Infections in Burns.[Lung Cancer and Respiratory Infections].Opportunistic bacterial, viral and fungal infections of the lungViral Respiratory Infections in Hematological PatientsFebrile neutropenia in paediatric oncologyCritical care management of adults with community-acquired severe respiratory viral infection", "title_abstract_phrases": "Critical care management of adults with community-acquired severe respiratory viral infectionWith the expanding use of molecular assays, viral pathogens are increasingly recognized among critically ill adult patients with community-acquired severe respiratory illness; studies have detected respiratory viral infections (RVIs) in 17\u201353% of such patients.Invasive fungal infections (Aspergillus, Mucorales, and Pneumocystis jirovecii) account for about 15% of severe respiratory infections, whereas parasites rarely cause severe acute infections in immunocompromised patients.Opportunistic bacterial, viral and fungal infections of the lungOpportunistic infections are a major cause of morbidity and mortality in severely immunocompromised patients, such as those given chemotherapy or biological therapies, and those with haematological malignancy, aplastic anaemia or HIV infection, or recipients of solid organ or stem cell transplants.Recognition and antiviral therapy are employed, but additional studies are necessary to improve outcomes in these patients.[Lung Cancer and Respiratory Infections].The frequency of respiratory infections as an infection in cancer patients is high.Diagnosis of severe respiratory infections in immunocompromised patientsAn increasing number of critically ill patients are immunocompromised."}